Daratumumab plus bortezomib-melphalan-prednisone (VMP) in elderly (≥75 y) patients (Pts) with newly diagnosed multiple myeloma (NDMM) ineligible for transplantation (ALCYONE).
暂无分享,去创建一个
A. Jakubowiak | S. Iida | Je-Jung Lee | J. San-Miguel | J. Bladé | M. Qi | S. Knop | M. Mateos | M. Cavo | I. Špička | M. Garg | Jianping Wang | V. Hungria | L. Pour | R. Kobos | P. Campbell | S. Wroblewski | M. Beksaç